HS LifeSciences

HS LifeSciences

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Switzerland, Zürich

About

HS LifeSciences was established in 2008, and is a well known Corporate Investor. The fund is located in Switzerland, Europe. The primary office of this Corporate Investor is located in Zürich.

The fund was created by Edward Stuart.

The fund usually participates in less than 2 investment rounds per year. Deals in the range of 5 - 10 millions dollars are most common for this fund. In 2009, the fund's activity was at its peak.

The fund typically invests alone.

Also, a start-up has to be aged 1 and less years to expect investment from this fund. The country of its establishment and the country of its most frequent investments coincides - Switzerland. We can highlight the most popular investment areas for this fund, such as Biotechnology, Apps. CT Atlantic is among the most popular portfolio start-up of the fund.

Year Founded

2008

Fund Activity

Not operative

Investments per Year [average amount of rounds in which fund participates each year]

<1

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: